Kp Tissue Stock Net Income
| KPTSF Stock | USD 7.49 0.07 0.93% |
Fundamental analysis of KP Tissue allows traders to better anticipate movements in KP Tissue's stock price by examining its financial health and performance throughout various phases of its business cycle.
KPTSF |
KP Tissue Company Net Income Analysis
KP Tissue's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current KP Tissue Net Income | 1.24 M |
Most of KP Tissue's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KP Tissue is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, KP Tissue reported net income of 1.24 M. This is 99.89% lower than that of the Household Products sector and 99.88% lower than that of the Consumer Staples industry. The net income for all United States stocks is 99.78% higher than that of the company.
KPTSF Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses KP Tissue's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of KP Tissue could also be used in its relative valuation, which is a method of valuing KP Tissue by comparing valuation metrics of similar companies.KP Tissue is currently under evaluation in net income category among its peers.
KPTSF Fundamentals
| Return On Equity | -0.0716 | |||
| Current Valuation | 74.38 M | |||
| Shares Outstanding | 9.94 M | |||
| Shares Owned By Insiders | 0.07 % | |||
| Shares Owned By Institutions | 18.82 % | |||
| Price To Earning | 85.11 X | |||
| Price To Book | 1.24 X | |||
| Net Income | 1.24 M | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | 8.43 X | |||
| Earnings Per Share | 0.09 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.59 | |||
| Market Capitalization | 76.14 M | |||
| Total Asset | 80.72 M | |||
| Annual Yield | 0.07 % | |||
| Net Asset | 80.72 M | |||
| Last Dividend Paid | 0.72 |
About KP Tissue Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze KP Tissue's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KP Tissue using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KP Tissue based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in KPTSF Pink Sheet
KP Tissue financial ratios help investors to determine whether KPTSF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPTSF with respect to the benefits of owning KP Tissue security.